Company intelligence / Profile preview

Headlight

Ownership: Private
Development stage: Commercial

Overview

Headlight provides tech-forward mental healthcare via telehealth and in-person visits. The company leverages data-driven approaches to streamline patient onboarding, aggregate medical/prescription history for holistic care, and match patients with appropriate clinicians. It has raised $18 million in venture funding to expand its network of licensed therapists across the U.S.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapy
Industry: Non-Academic Healthcare

Drug pipeline

1 asset

esketamine

Commercial

Indications: Treatment-resistant depression

Partnerships

Investors: Matrix PartnersInvestors: Epic VenturesTJ Parker (founder of PillPack/former Amazon Pharmacy executive) joined Matrix as general partner and has influence through investment.

Beyond the preview

Go deeper on Headlight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Headlight.

Explore the full profile